April 28, 2026- Thermo Fisher Scientific Inc. announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faster. The facility demonstrates Thermo Fisher’s continued commitment to empowering customers as a trusted innovation partner.
The BDC features 4,000 square feet of laboratory and training space to support customers in developing biologics, including vaccines and cell and gene therapies. Customers will experience Thermo Fisher’s complete, end-to-end bioproduction workflow of integrated, scalable solutions – including media, cell line development, single-use systems, chromatography, filtration, purification and analytics – that can unlock productivity gains and reduce time to market.
Onsite bioprocess specialists provide hands-on demonstrations, training and technical consulting. Experts work directly with customers to test and refine processes, validate concepts and address complex challenges to help them move from development to scalable production with greater speed and confidence.